IRLA
IRulya Therapeutics Inc.
IRLA | NASDAQ
$33.03
+$0.08 (+0.24%)
At close: Nov 2, 2026, 3:59 PM ET
$32.95
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 8:26 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -92.48M | -33.04M | -83.98M | -56.98M | -49.03M | -60.71M | -56.83M | -53.26M | -53.12M | -30.28M | -31.39M | -28.03M | -30.6M | -42.27M | -51.66M | -69.53M | -83.31M | -88.5M | -89.95M | -87.1M | -86.9M | -82.76M |
Depreciation & Amortization | 152K | 146K | 142K | 119K | 169K | 178K | 186K | 474K | 388K | 345K | 322K | 60K | 100K | 183K | 204K | 246K | 293K | 296K | 344K | 345K | 342K | 335K |
Stock-Based Compensation | 15.83M | 5.01M | 5.11M | 5.04M | 4.91M | 4.86M | 4.75M | 4.71M | 4.91M | 5.01M | 5.22M | 5.77M | 5.13M | 8.86M | 16.62M | 23.48M | 30.4M | 32.1M | 29.85M | 26.32M | 22.86M | 19.51M |
Other Working Capital | -16.02M | -8.61M | 13.78M | 703K | 2.81M | 1.48M | -1.41M | -1.58M | -2.39M | 877K | 2.27M | 735K | 1.25M | -679K | -3.89M | -4.56M | -4.22M | -11.12M | -5.62M | -1.1M | 3.56M | 10.23M |
Other Non-Cash Items | 38.95M | -7.91M | 24.46M | 11.06M | 6.2M | 20.15M | 20.48M | 21.6M | 23.71M | 4.1M | 7.64M | 4.44M | 5.93M | 6.61M | 913K | 1.32M | 797K | 918K | 1.08M | 1.18M | 1.22M | 1.15M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.82M | -1.82M | -1.82M | -2.07M | -248K | -248K | -532K | -284K | -284K | -284K | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -9.37M | -3.66M | 12.84M | 2.27M | 1.92M | 2.37M | -484K | -2.13M | -2.06M | -433K | 1.98M | -40K | -242K | -4.36M | -9.83M | -7.86M | -11.17M | -10.23M | -4.26M | -2.53M | 5.66M | 8.12M |
Operating Cash Flow | -46.92M | -39.45M | -41.43M | -38.5M | -35.83M | -33.15M | -31.9M | -30.43M | -27.99M | -23.08M | -18.29M | -18.05M | -19.93M | -31.52M | -44.04M | -52.62M | -63.27M | -65.41M | -62.93M | -61.79M | -56.82M | -53.65M |
Capital Expenditures | -78K | -204K | -352K | -481K | -453K | -366K | -257K | -148K | -102K | -63K | -160K | -214K | -264K | -264K | -133K | -99K | -49K | -148K | -180K | -146K | -166K | -84K |
Cash Acquisitions | 8M | n/a | n/a | n/a | n/a | n/a | n/a | -2.12M | -2.12M | -2.12M | -2.12M | n/a | n/a | n/a | 135K | 135K | 135K | 135K | n/a | n/a | n/a | n/a |
Purchase of Investments | -20.63M | -32.46M | -34.42M | -29.5M | -17.63M | -52.22M | -89.56M | -108.23M | -149.37M | -145.38M | -113.78M | -103.37M | -88.3M | -73.76M | -75.02M | -69.78M | -50.47M | -35.77M | -38.79M | -39.56M | -72.9M | -103.58M |
Sales Maturities Of Investments | 38.94M | 57M | 57.64M | 55.16M | 52.15M | 75.64M | 111.24M | 127.42M | 165.55M | 146.18M | 111.21M | 111.51M | 83.5M | 73.4M | 82.49M | 79.47M | 69.74M | 76.64M | 97.92M | 93.57M | 136.53M | 155.56M |
Other Investing Acitivies | 62K | n/a | 355K | 845K | 845K | 845K | 490K | -500K | -1M | -1M | -910K | -410K | 125K | 10.75M | 10.53M | 10.53M | 10.49M | -135K | n/a | n/a | n/a | n/a |
Investing Cash Flow | 26.29M | 24.33M | 23.23M | 26.02M | 34.91M | 23.89M | 21.91M | 16.43M | 12.96M | -2.38M | -5.76M | 7.52M | -4.94M | 10.13M | 18M | 20.26M | 29.85M | 40.72M | 58.95M | 53.86M | 63.46M | 51.89M |
Debt Repayment | -5.55M | -5.55M | n/a | n/a | n/a | n/a | n/a | -6K | -6K | -6K | -12K | -24K | -43K | -55K | -49K | -31K | -12K | n/a | n/a | -2K | -2K | -5K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -56K | n/a | n/a | n/a | -5M | -5M | -5M | -4.99M | 6K | 6K | 62K | 56K | 70K | 190K | 148K | 148K | 134K | 14K | n/a | 47K | 47K | 1M |
Financial Cash Flow | 121.79M | 27.27M | 17.91M | 15.88M | 9.5M | -4.88M | -4.78M | -4.72M | 292K | 283K | 143K | 68K | 53K | 135K | 707K | 1.72M | 6.43M | 6.99M | 6.81M | 5.86M | 1.25M | 1.47M |
Net Cash Flow | 99.16M | 10.39M | -403K | 3.78M | 8.94M | -14.04M | -14.54M | -18.96M | -14.76M | -24.9M | -23.83M | -10.18M | -24.28M | -20.85M | -25.15M | -30.4M | -27.12M | -17.75M | 2.88M | -2.04M | 7.89M | -291K |
Free Cash Flow | -47M | -39.66M | -41.78M | -38.98M | -36.28M | -33.52M | -32.16M | -30.58M | -28.09M | -23.14M | -18.45M | -18.26M | -20.19M | -31.78M | -44.17M | -52.72M | -63.32M | -65.56M | -63.11M | -61.94M | -56.99M | -53.73M |
Adj. Free Cash Flow | -62.83M | -44.66M | -46.88M | -44.02M | -41.19M | -38.38M | -36.91M | -35.29M | -33M | -28.15M | -23.67M | -24.03M | -25.32M | -40.64M | -60.79M | -76.2M | -93.72M | -97.66M | -92.97M | -88.26M | -79.84M | -73.24M |
Maintenance CapEx | -40K | -75K | -107K | -119K | -129K | -133K | -140K | -148K | -102K | -63K | -41K | -59K | -99K | -99K | -87K | -89K | -49K | -136K | -168K | -134K | -154K | -84K |
Growth CapEx | -38K | -129K | -245K | -362K | -324K | -233K | -117K | n/a | n/a | n/a | -119K | -155K | -165K | -165K | -46K | -10K | n/a | -12K | -12K | -12K | -12K | n/a |
Owner Earnings | -46.96M | -39.53M | -41.53M | -38.62M | -35.96M | -33.29M | -32.04M | -30.58M | -28.09M | -23.14M | -18.33M | -18.11M | -20.03M | -31.62M | -44.13M | -52.71M | -63.32M | -65.55M | -63.1M | -61.92M | -56.97M | -53.73M |
Add to Watchlist
Select watchlists to add or remove IRLA